Onco-Innovations Extends Marketing Program
VANCOUVER, BC / ACCESS Newswire / March 25, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ('Onco' or the 'Company') announces that it has extended the term of its engagement with MCS Market Communication Service GmbH (business address: Rheinpromenade 13, 40789 Monheim am Rhein, Nordrhein-Westfalen, Deutschland, email: [email protected]; telephone: +491772481220; and website: www.mcsmarket.de) ('MCS') for the continued provision of a range of online marketing services, including campaign creation, production of marketing materials, as well as research and analytics (the 'Services'). The Services are expected to run until May 31, 2025, or until budget exhaustion. The Company has paid MCS CAD 600,000 for the extended term of Services, and no securities have been provided to MCS or its principals as compensation. The Services will be executed via digital channels, including Google Ads and native advertising.
About Onco-Innovations Limited
Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to prevent and cure cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide license to patented technology that targets solid tumours, setting new standards in cancer treatment. Onco's commitment to excellence and innovation drives it to develop advanced therapies that improve patient outcomes and offer hope in the fight against cancer.
ON BEHALF OF ONCO-INNOVATIONS LIMITED,
'Thomas O'Shaughnessy'
Chief Executive Officer
For more information, please contact:
Thomas O'Shaughnessy
Chief Executive Officer
Tel: + 1 888 261 8055
The CSE and Information Service Provider have not reviewed and do not accept responsibility for the accuracy or adequacy of this release.
Forward-Looking Statements Caution. This news release contains forward-looking statements relating to the further development, potential commercialization and benefits of the Company's technologies, the Company's ability to complete future research and development activities with respect thereto, and the prospects of the Company, and the Company's business and plans generally, and other statements that are not historical facts. Forward-looking statements are often identified by terms such as 'will', 'may', 'potential', 'should', 'anticipate', 'expects' and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to further develop, prove out or commercialize its technologies, the failure to complete further research and development activities in respect thereto, the failure to receive regulatory approval in respect of its technologies, and other risks detailed from time to time in the filings made by the Company with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
FDA: More cucumbers, ready-to-eat products recalled in growing salmonella outbreak
A Maryland food company has recalled specific salsa and cucumber products because they were made with cucumbers that are possibly contaminated with salmonella. TGD Cuts, LLC of Jessup, Maryland, is recalling some tub and tray products because they contained cucumbers from Boynton Beach, Florida-based Bedner Growers Inc., which have been linked to a salmonella outbreak. TGD Cuts distributed the affected products, which included salsas, sliced cucumbers and cucumber spears, to retail and foodservice locations in Maryland, Virginia, Pennsylvania, New Jersey, and North Carolina, according to the Food and Drug Administration (FDA). The products had use-by dates ranging from May 20 to May 28 and are unlikely to be in stores or being used. No illnesses have been reported in connection with the products, the FDA said. Egg recall: Brown eggs sold at some Walmart stores have salmonella risk The initial May 19 recall involved cucumbers sold directly to consumers at Bednar's Farm Fresh Market, according to notices published May 19 by the Centers for Disease Control and Prevention (CDC) and the FDA. Subsequent recalls have been announced by grocers such as Harris Teeter, Kroger and Walmart for repackaged cucumbers for resale under different brand names or those used in ready-to-eat products, including vegetable trays and salads. The cucumbers, distributed by Fresh Start Produce Sales of Delray, Florida, also led to Target recalling individual cucumbers on May 30, specifically cucumber two-packs and various prepared foods products. In addition to the growing cucumber-related recall, other products have been recalled recently for potential salmonella contamination. The FDA on May 28 upgraded a recall of tomatoes distributed in three southern states to a Class I recall, meaning consumption of the food could cause serious health complications or lead to death. Then, on June 6, the CDC and FDA linked brown eggs sold in nine states – including at some Walmart stores – to an ongoing Salmonella Enteritidis outbreak, in which 79 people have been sickened and at least 21 hospitalized. Customers who purchased any products from TGD Cuts should get rid of them or return them for a full refund. Here is the list of products recalled due to a possible salmonella risk. Item UPC Use By Date Salsa, Hot 6/12 oz. 840219170534 5/25/2025 Salsa, Mild 6/12 oz. 840219170541 5/25/2025 Salsa, Mild 5lb. 840219140445 not available Salsa, Mild 5lb. 840219140445 5/28/2025 Cucumber Sliced/Grape Tomato 50/2 oz. 840219184784 5/23/2025 Cucumber Sliced Unpeeled 5lb. 840219160733 not available Cucumber Sliced Unpeeled 50/2 oz. 840219170657 5/19/2025 Cucumber Spears 50/2 oz. 840219179971 5/19/2025 Salmonella poisoning causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths each year in the U.S., according to the CDC and FDA. Symptoms, which include diarrhea, fever and stomach cramps, will usually occur six hours to six days after exposure and may last up to seven days. Symptoms from severe infections may include aches, headaches, elevated fever, lethargy, rashes, and blood in urine or stool. Mike Snider is a reporter on USA TODAY's Trending team. You can follow him on Threads, Bluesky, X and email him at mikegsnider & @ & @mikesnider & msnider@ What's everyone talking about? Sign up for our trending newsletter to get the latest news of the day This article originally appeared on USA TODAY: More cucumbers recalled for salmonella risk, FDA says
Hamilton Spectator
42 minutes ago
- Hamilton Spectator
Marc Garneau left lasting legacy on Earth and in space, former colleagues say
MONTREAL - Canadian scientists working on asteroid missions, exploring the universe through the James Webb Space Telescope or helping to put rovers on Mars say they can in some way thank Marc Garneau, who left an enduring legacy both as an astronaut and head of the country's space agency. While best-known in later years as a federal cabinet minister, Garneau, who died this week at 76, was also a Navy officer, a systems engineer, and an astronaut with a lifelong passion for science, according to his friends and colleagues. In 1984, he made history as the first Canadian in space when he served as a payload specialist aboard the Space Shuttle Challenger. He returned to space twice more, in 1996 and 2000, before serving as the president of the Canadian Space Agency from 2001 to 2005. 'All his life was devoted to public service,' said Gilles Leclerc, an ex-CSA official who worked with him. 'And he was really a role model to all the Canadian astronauts who came after him.' As CSA president, Garneau laid the building blocks for the space exploration program that would bring together other initiatives previously developed separately, Leclerc said. He was also 'ahead of his time' when it came to being conscious of the environment and understanding the importance of applying space technology for practical uses such as satellite communications. 'During his tenure, he really wanted us to focus more on science: astronomy, planetary science, lunar exploration,' Leclerc said in a phone interview. 'So all these things that now we see, all these missions that Canada participated in, like a mission to the asteroids, two missions to Mars, the James Webb Space had a real strong influence in shaping the future of the space program for a long time.' On Friday, CSA President Lisa Campbell paid tribute to Garneau, who she called a 'cherished member of the space agency family.' 'We remain deeply grateful for his extraordinary public service and enduring contributions to Canada and the world, from making history as the first Canadian in space to guiding the Canadian Space Agency as its president,' she said at an event at the agency's Montreal-area headquarters. 'his integrity, his generosity of spirit touches everyone who had the privilege of working with him.' Flags at government buildings in Montreal have been lowered to half-mast in tribute. Garneau would carry his love of science — as well as his significant technical knowledge — into his next role as a politician, according to his former chief of staff and close personal friend. Marc Roy said Garneau decided to run for office out of a desire to give back after his successful space career. Garneau often spoke about how seeing the Earth from above 'changed his perspective on many things,' including conflicts and environmental protections, Roy said. 'So many things that unfortunately divide us as humans that become so irrelevant when you look at our world from abroad,' Roy said in a phone interview. 'And that desire to want to contribute at an even higher level, at a different, at a policy level, at a governance level is what inspired him to run for federal politics.' Garneau was elected as MP in Notre-Dame-de-Grâce–Westmount in 2008 after failing to win another Montreal-area seat in 2006. Roy said Garneau's scientific background shone through most clearly as Transport minister, when he was able to instantly grasp technical briefings on ships, planes and trains. Above all, his history as a naval officer and astronaut gave him a laser focus on safety, Roy said, in a role that would see Garneau introduce measures including the safer skies initiative, and the oceans protection plan to monitor ship traffic, oil spills and wildlife. Roy said Garneau often spoke about the weight of the portfolio, 'wanting to ensure that he did it to the best of his ability, that he truly understood every decision that he was taking and every decision that was possible for him to make in order to ensure the safety of the traveling public and the safety overall of our trade and transportation corridors.' Roy said Garneau brought a scientist's analytic, 'Spock-like' demeanor to his roles. But he said some of the issues Garneau championed most passionately were social causes, including serving as a joint chair of the special joint committee on medical assistance in dying. And, despite his considerable intelligence, Roy said Garneau remained humble. 'He had a very rare quality in a politician, from his very debut until the very last day before he retired as member of Parliament, which was: he listened more than he talked,' Roy said. He said his friend was diagnosed only months ago with two cancers: leukemia and lymphoma, and died after a battle that was 'brave but short.' Roy said his friend's time since retirement was spent enjoying time with his wife, Pam, and his children, and completing work on his autobiography, 'A Most Extraordinary Ride: Space, Politics and the Pursuit of a Canadian Dream.' Roy said the book gave Garneau closure. 'He wanted to tell the story that, 'I'm just like everybody else and I failed and I've screwed up and I pulled up my socks and I learned from my mistakes and I moved on,'' Roy said. 'And that was very important for him to tell that story, and I'm just so fortunate that he had the time to do that.' This report by The Canadian Press was first published June 7, 2025.
Yahoo
an hour ago
- Yahoo
Ro Weight Loss Announces Official Website Update Featuring Natural Daily Program for Medically-Guided Weight Management
Digital health platform offers FDA-approved treatments when appropriate and personalized care plans through licensed providers. New York, June 07, 2025 (GLOBE NEWSWIRE) -- Ro Weight Loss, a digital health service from Roman Health Ventures Inc., has updated its official website to provide new information about its medically-guided weight management program. Designed for adults across the United States, the offering connects eligible individuals with licensed healthcare providers through a secure telehealth platform. According to the official website ( Ro Weight Loss offers a structured approach to weight care, including FDA-approved treatment options when appropriate, along with personalized clinical support and lifestyle guidance. The service is designed to be accessible from home and does not require in-person clinic visits or restrictive dietary regimens. 'We created Ro Weight Loss to make effective, evidence-backed care more accessible,' said a Ro spokesperson. 'Our platform empowers people with a personalized plan, clinical oversight, and flexible support tailored to their health goals.' Ro states that the program prioritizes safety, transparency, and sustainable progress. After completing an online health assessment, users may be evaluated by board-certified providers to determine medical eligibility. When appropriate, providers may prescribe treatment as part of a comprehensive plan that includes coaching and follow-up. All care is delivered by licensed professionals, and medications are dispensed by U.S.-based pharmacies. The platform supports discreet access to care, ongoing communication with providers, and convenience for users managing their health goals remotely. The Ro Weight Loss program is currently available in all 50 states. Individuals interested in exploring eligibility or learning more about the service can visit the official website for additional information. About Ro Weight Loss Ro Weight Loss is a service provided by Roman Health Ventures Inc., a New York-based telehealth company offering evidence-based treatment across multiple areas of care, including weight management, mental health, dermatology, and more. Ro's digital platform empowers individuals to receive safe, personalized healthcare from the comfort of home. Product and Contact Information Brand: Ro Weight LossWebsite: care@ Address:Roman Health Ventures Inc.625 6th Ave, 4th FloorNew York, NY 10011 Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this program have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new treatment plan. Affiliate Disclosure This news release contains affiliate links. If you purchase through these links, the publisher may earn a commission at no additional cost to you. This disclosure complies with the Federal Trade Commission's guidelines on endorsements and testimonials in advertising. All opinions expressed are strictly those of the author or publisher. CONTACT: Email: care@
